Netflix's New Wonka Spin-Off Sparks Backlash as Fifth Adaptation Announced
Netflix's New Wonka Spin-Off Sparks Backlash as Fifth Adaptation

Netflix Announces Fifth Charlie and the Chocolate Factory Adaptation

Netflix has confirmed plans to release a new animated spin-off of Roald Dahl's beloved book, Charlie and the Chocolate Factory, titled Charlie vs the Chocolate Factory. This marks the fifth adaptation of the classic story, sparking widespread debate over its necessity and originality.

Plot Details and Casting Revealed

The film, scheduled for a 2027 release, will be directed by Taika Waititi, who also stars as Willy Wonka. Kit Connor, known for Heartstopper, leads as a new character, Charlie Paley. Set in modern-day London, the story explores the aftermath of the original book, with Wonka returning from prison after turning a child into a blueberry. Charlie Paley and his friends plot to steal a priceless Wonka bar to save their homes, a premise that has left many fans confused online.

Timing and Industry Context

This announcement comes just three years after the Timothée Chalamet-led prequel, Wonka, and amid reports of a sequel starring Saoirse Ronan, potentially releasing in December 2027. With two adaptations slated within months, critics argue this represents overkill, questioning whether the world needs so many retellings of the same mad chocolatier tale.

Wide Pickt banner — collaborative shopping lists app for Telegram, phone mockup with grocery list

Historical Adaptations and Fan Reception

Previous adaptations include the 1971 film starring Gene Wilder, the 2005 version with Johnny Depp, and the recent prequel. While these have been well-received, the new spin-off raises concerns about creative stagnation. Netflix acquired the Roald Dahl Story Company in 2021, leading to adaptations like The Wonderful Story of Henry Sugar, which won an Oscar, but also the poorly rated animated The Twits in 2025.

Alternatives and Criticism

Many suggest Netflix should explore untold Dahl gems, such as George's Marvellous Medicine or The Giraffe and the Pelly and Me, rather than relying on familiar IP. Critics argue that a stronger project would ditch ties to existing stories and focus on original filmmaking, rather than riding on predecessors' coattails.

Despite skepticism, some remain open to the possibility of a masterpiece, though doubts persist about its groundbreaking potential. The debate highlights broader industry trends towards remakes over new ideas.

Pickt after-article banner — collaborative shopping lists app with family illustration